Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Supply Chain
india_pharma_flag_shutterstockfinal
Indian pharma companies look for options beyond US amid tariff threat: GlobalData
Overseas markets take on increased attractiveness for India following President Trump’s threatened tariffs on generic drugs in 2028, finds data and analytics firm.
Oct. 13, 2026
cphipanel
GLP-1 demand puts strain on production capacity, supply chains
Oct. 7, 2026
chinauspillsfinal_shutterstock
Manufacturing of new FDA-approved drugs moving to China: GlobalData
Sept. 28, 2026
trump
Trump strikes drug pricing, tariff deals with nine mid-sized biopharma companies
Sept. 1, 2026
germanypillsshutterstock
German drug manufacturers face biggest hit from US supply chain bill: GlobalData
Aug. 18, 2026
fdawhiteoakbuilding
FDA’s GDUFA IV commitment letter supports onshoring of generic drug manufacturing
Aug. 13, 2026
departmentcommerceshutterstock
Department of Commerce funds biomanufacturing, pharma manufacturing hubs
July 22, 2026
congress_shutterstock
Senators sponsor bill seeking transparency on foreign control in US drug supply chain
July 17, 2026
fdawhiteoakbuilding
FDA proposed rule eases drug manufacturing registration, boosts foreign source visibility
July 13, 2026
Looking for Something?
Load More Content
